Terms: = Gastric cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
395 results:
1. Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.
Ni M; Zhang Y; Sun Z; Zhou Q; Xiao J; Zhang B; Lin J; Gong B; Liu F; Meng F; Zheng G; Wang Y; Gu L; Li L; Shen W; Chen Y; Liu Y; Li L; Ling T; Cheng H
Phytomedicine; 2024 May; 127():155496. PubMed ID: 38471368
[TBL] [Abstract] [Full Text] [Related]
2. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
Yau T; Kaseb A; Cheng AL; Qin S; Zhu AX; Chan SL; Melkadze T; Sukeepaisarnjaroen W; Breder V; Verset G; Gane E; Borbath I; Rangel JDG; Ryoo BY; Makharadze T; Merle P; Benzaghou F; Milwee S; Wang Z; Curran D; Kelley RK; Rimassa L
Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):310-322. PubMed ID: 38364832
[TBL] [Abstract] [Full Text] [Related]
3. Enantiomer-Specific Colorimetric Tandem Assays for Salivary d-Alanine Associated with gastric cancer.
Liu C; Wu Y; Li M; Liu F; Kong P; Yang H; Liu X
Anal Chem; 2024 Feb; 96(5):1906-1912. PubMed ID: 38251936
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
[TBL] [Abstract] [Full Text] [Related]
5. First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
Leidner R; Conlon K; McNeel DG; Wang-Gillam A; Gupta S; Wesolowski R; Chaudhari M; Hassounah N; Lee JB; Ho Lee L; O'Keeffe JA; Lewis N; Pavlakis GN; Thompson JA
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907221
[TBL] [Abstract] [Full Text] [Related]
6. cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in cancer Burden, 2020-2050: A Statistical Modeling Study.
Nguyen PT; Hori M; Matsuda T; Katanoda K
Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1756-1770. PubMed ID: 37756571
[TBL] [Abstract] [Full Text] [Related]
7. First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Cytryn SL; Moy RH; Cowzer D; Shah RH; Chou JF; Joshi SS; Ku GY; Maron SB; Desai A; Yang J; Sugarman R; Rao D; Goldberg Z; Charalambous C; Lapshina M; Antoine A; Socolow F; Trivedi N; Capanu M; Gerdes H; Schattner MA; Simmons M; Lacouture ME; Paroder V; Tang LH; Shia J; Ilson DH; Solit DB; Berger MF; Janjigian YY
Lancet Oncol; 2023 Oct; 24(10):1073-1082. PubMed ID: 37666264
[TBL] [Abstract] [Full Text] [Related]
8. Computed Tomography-Based Predictive Model for the Probability of Lymph Node Metastasis in gastric cancer: A Meta-analysis.
Teng F; Fu YF; Wu AL; Xian YT; Lin J; Han R; Yin YF
J Comput Assist Tomogr; 2024 Jan-Feb 01; 48(1):19-25. PubMed ID: 37551145
[TBL] [Abstract] [Full Text] [Related]
9. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
Alshareefy Y; Shen CY; Prekash RJ
Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
[TBL] [Abstract] [Full Text] [Related]
10. Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach.
Kong SH; Kurokawa Y; Yook JH; Cho H; Kwon OK; Masuzawa T; Lee KH; Matsumoto S; Park YS; Honda H; Ryu SW; Ishikawa T; Kang HJ; Nabeshima K; Im SA; Shimokawa T; Kang YK; Hirota S; Yang HK; Nishida T
Gastric Cancer; 2023 Sep; 26(5):775-787. PubMed ID: 37351703
[TBL] [Abstract] [Full Text] [Related]
11. Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415).
Lorenzen S; Schwarz A; Pauligk C; Goekkurt E; Stocker G; Knorrenschild JR; Illerhaus G; Dechow T; Moehler M; Moulin JC; Pink D; Stahl M; Schaaf M; Goetze TO; Al-Batran SE
BMC Cancer; 2023 Jun; 23(1):561. PubMed ID: 37337155
[TBL] [Abstract] [Full Text] [Related]
12. A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma.
Sun W; Veeramachaneni N; Al-Rajabi R; Madan R; Kasi A; Al-Kasspooles M; Baranda J; Saeed A; Phadnis MA; Godwin AK; Olyaee M; Streeter N; Nagji A; Dai J; Williamson S
Cancer Med; 2023 Aug; 12(15):16098-16107. PubMed ID: 37326317
[TBL] [Abstract] [Full Text] [Related]
13. Expression of PD-L1 and VISTA in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma of the Pancreas.
Mo S; Zou L; Hu Y; Chang X; Chen J
Mod Pathol; 2023 Sep; 36(9):100223. PubMed ID: 37244388
[TBL] [Abstract] [Full Text] [Related]
14. Impact of bariatric surgery on early-onset colorectal cancer risk: a systematic review and meta-analysis.
Bustamante-Lopez L; Sulbaran M; Changoor NR; Tilahun Y; Garcia-Henriquez N; Albert M; Soliman M; Monson JRT; Pepe J
Updates Surg; 2023 Aug; 75(5):1051-1057. PubMed ID: 37178403
[TBL] [Abstract] [Full Text] [Related]
15. Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study.
Liu D; Kou F; Gong J; Wang Z; Zhang X; Li J; Li Y; Li J; Zhou J; Lu M; Wang X; Lu Z; Cao Y; Zou J; Zhu X; Xu R; Shen L
Cancer Med; 2023 May; 12(9):10704-10714. PubMed ID: 37081722
[TBL] [Abstract] [Full Text] [Related]
16. Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study.
Lapébie FX; Bura-Rivière A; Espitia O; Bongard V; Ciammaichella MM; Martínez JG; Sigüenza P; Giménez JC; Bertoletti L; Monreal M
J Thromb Haemost; 2023 Aug; 21(8):2189-2201. PubMed ID: 37068594
[TBL] [Abstract] [Full Text] [Related]
17. [Pathological evaluation of endoscopic submucosal dissection for early gastric cancer and precancerous lesion in 411 cases].
Liu JM; Liang L; Zhang JX; Rong L; Zhang ZY; Wu Y; Zhao XD; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):299-307. PubMed ID: 37042141
[TBL] [Abstract] [Full Text] [Related]
18. Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway.
Yu YH; Zhang HJ; Yang F; Xu L; Liu H
J Ethnopharmacol; 2023 Jun; 310():116311. PubMed ID: 36894110
[TBL] [Abstract] [Full Text] [Related]
19. [Factors associated with readmission within three months of surgery for gastric cancer and their long-term effects on patients' nutritional status and quality of life].
Yan HX; He F; Chen YT; Guo CG; Wei JJ; Zhao DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Feb; 26(2):191-198. PubMed ID: 36797566
[No Abstract] [Full Text] [Related]
20. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
[Next]
